Deuruxolitinib launches in the United States for severe alopecia areata, offering sustained hair regrowth, strong clinical results, and improved patient access support.
FDA Approves New Pill for Severe Alopecia Areata (Patchy Hair Loss)
Deuruxolitinib launches in the United States for severe alopecia areata, offering sustained hair regrowth, strong clinical results, and improved patient access support.